EDRONAX reboxetine 4mg (as mesilate) tablet       blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

edronax reboxetine 4mg (as mesilate) tablet blister pack

pfizer australia pty ltd - reboxetine mesilate, quantity: 5.224 mg (equivalent: reboxetine, qty 4 mg) - tablet, uncoated - excipient ingredients: calcium hydrogen phosphate dihydrate; microcrystalline cellulose; crospovidone; magnesium stearate; silicon dioxide - indications: edronax is indicated for the treatment of major depression and is effective in preventing the relapse of depressive symptoms.

TEVETEN eprosartan 600mg (as mesilate) tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

teveten eprosartan 600mg (as mesilate) tablet blister pack

viatris pty ltd - eprosartan mesilate, quantity: 735.8 mg (equivalent: eprosartan, qty 600 mg) - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; crospovidone; magnesium stearate; pregelatinised maize starch; hypromellose; macrogol 400; polysorbate 80; titanium dioxide - teveten is indicated for the treatment of essential hypertension.

ALZIRAS rasagiline (as mesilate) 1 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

alziras rasagiline (as mesilate) 1 mg tablet blister pack

arrotex pharmaceuticals pty ltd - rasagiline mesilate, quantity: 1.56 mg (equivalent: rasagiline, qty 1 mg) - tablet - excipient ingredients: citric acid monohydrate; pregelatinised maize starch; purified talc; colloidal anhydrous silica; microcrystalline cellulose; stearic acid; maize starch - rasagiline is indicated for the symptomatic treatment of idiopathic parkinson?s disease (pd) as monotherapy and as adjunct therapy to dopamine agonists or to levodopa.

RASAGILINE-TEVA rasagiline (as mesilate) 1 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

rasagiline-teva rasagiline (as mesilate) 1 mg tablet blister pack

teva pharma australia pty ltd - rasagiline mesilate, quantity: 1.56 mg (equivalent: rasagiline, qty 1 mg) - tablet - excipient ingredients: stearic acid; purified talc; mannitol; colloidal anhydrous silica; maize starch; pregelatinised maize starch - rasailine-teva is indicated for the symptomatic treatment of idiopathic parkinson?s disease (pd) as monotherapy and as adjunct therapy to dopamine agonists or to levodopa.

RASALECT rasagiline (as mesilate) 1 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

rasalect rasagiline (as mesilate) 1 mg tablet blister pack

teva pharma australia pty ltd - rasagiline mesilate, quantity: 1.56 mg (equivalent: rasagiline, qty 1 mg) - tablet - excipient ingredients: stearic acid; purified talc; mannitol; colloidal anhydrous silica; maize starch; pregelatinised maize starch - rasalect is indicated for the symptomatic treatment of idiopathic parkinson?s disease (pd) as monotherapy and as adjunct therapy to dopamine agonists or to levodopa.

Hospira Desferrioxamine Mesilate 500 mg Powder for Injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

hospira desferrioxamine mesilate 500 mg powder for injection vial

hospira australia pty ltd - desferrioxamine mesilate, quantity: 500 mg - injection - excipient ingredients: - desferrioxamine mesilate is a binding agent for iron and aluminium. desferrioxamine mesilate is used to remove excess iron or aluminium from the body in patients with conditions such as iron poisoning, thalassemia (a heredity type of anemia) haemochromatosis (a disorder of iron metabolism) and aluminium overload due to kidney failure. it may also be used to diagnose iron storage disease and some types of chronic anemias or aluminium overload in some patients.

STEMETIL prochlorperazine mesilate 12.5mg/1mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

stemetil prochlorperazine mesilate 12.5mg/1ml injection ampoule

sanofi-aventis australia pty ltd - prochlorperazine mesilate, quantity: 12.5 mg/ml - injection, solution - excipient ingredients: water for injections; sodium metabisulfite; sodium chloride; monoethanolamine; sodium sulfite - nausea and vomiting due to various causes including migraine; vertigo due to meniere's syndrome, labyrinthitis and other causes.

ZELDOX IM ziprasidone (as mesilate) 20 mg powder for injection vial with diluent Australia - English - Department of Health (Therapeutic Goods Administration)

zeldox im ziprasidone (as mesilate) 20 mg powder for injection vial with diluent

viatris pty ltd - ziprasidone mesilate, quantity: 27.29 mg (equivalent: ziprasidone, qty 20 mg) - injection, powder for - excipient ingredients: sulfobutyl betadex sodium - acute control and short-term management of agitation and disturbed behaviours in patients with schizophrenia and related psychoses when oral therapy is not appropriate.

OHTAS ISAN ANTACID- magnesium aluminosilicate, calcium carbonate, sodium bicarbonate tablet United States - English - NLM (National Library of Medicine)

ohtas isan antacid- magnesium aluminosilicate, calcium carbonate, sodium bicarbonate tablet

ohta's isan co., ltd - almasilate (unii: ozq8o62h53) (almasilate - unii:ozq8o62h53), calcium carbonate (unii: h0g9379fgk) (calcium cation - unii:2m83c4r6zb, carbonate ion - unii:7ujq5ope7d), sodium bicarbonate (unii: 8mdf5v39qo) (bicarbonate ion - unii:hn1zra3q20) - almasilate 125 mg - magnesium aluminometasilicate ............ antacid  precipitated calcium carbonate ............. antacid sodium bicarbonate ............................. antacid relieves: ■ heartburn ■ acid indigestion ■ sour stomach ■ upset stomach due to these symptoms ■ presently taking a prescription drug. antacids may interact with certain prescription drugs, ■ on a sodium-restricted diet